• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估英格兰心血管疾病中存在的长期趋势可能对心血管疾病风险预测造成的潜在误判。

An assessment of the potential miscalibration of cardiovascular disease risk predictions caused by a secular trend in cardiovascular disease in England.

机构信息

Division of Imaging, Informatics and Data Science, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Oxford Road, Manchester, M13 9PL, UK.

Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crispigny Park, London, SE5 8AF, UK.

出版信息

BMC Med Res Methodol. 2020 Nov 30;20(1):289. doi: 10.1186/s12874-020-01173-x.

DOI:10.1186/s12874-020-01173-x
PMID:33256644
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7706224/
Abstract

BACKGROUND

A downwards secular trend in the incidence of cardiovascular disease (CVD) in England was identified through previous work and the literature. Risk prediction models for primary prevention of CVD do not model this secular trend, this could result in over prediction of risk for individuals in the present day. We evaluate the effects of modelling this secular trend, and also assess whether it is driven by an increase in statin use during follow up.

METHODS

We derived a cohort of patients (1998-2015) eligible for cardiovascular risk prediction from the Clinical Practice Research Datalink with linked hospitalisation and mortality records (N = 3,855,660). Patients were split into development and validation cohort based on their cohort entry date (before/after 2010). The calibration of a CVD risk prediction model developed in the development cohort was tested in the validation cohort. The calibration was also assessed after modelling the secular trend. Finally, the presence of the secular trend was evaluated under a marginal structural model framework, where the effect of statin treatment during follow up is adjusted for.

RESULTS

Substantial over prediction of risks in the validation cohort was found when not modelling the secular trend. This miscalibration could be minimised if one was to explicitly model the secular trend. The reduction in risk in the validation cohort when introducing the secular trend was 35.68 and 33.24% in the female and male cohorts respectively. Under the marginal structural model framework, the reductions were 33.31 and 32.67% respectively, indicating increasing statin use during follow up is not the only the cause of the secular trend.

CONCLUSIONS

Inclusion of the secular trend into the model substantially changed the CVD risk predictions. Models that are being used in clinical practice in the UK do not model secular trend and may thus overestimate the risks, possibly leading to patients being treated unnecessarily. Wider discussion around the modelling of secular trends in a risk prediction framework is needed.

摘要

背景

通过之前的工作和文献研究,发现英格兰心血管疾病(CVD)的发病率呈下降趋势。心血管疾病一级预防的风险预测模型并未对这种长期趋势进行建模,这可能导致对当今个体风险的过高预测。我们评估了对这种长期趋势进行建模的效果,同时还评估了这种长期趋势是否是由于在随访期间他汀类药物使用率的增加而导致的。

方法

我们从临床实践研究数据链中提取了一个符合心血管风险预测条件的患者队列(1998-2015 年),并与住院和死亡记录相关联(N=3855660)。根据患者入组日期(2010 年之前/之后),将患者分为开发和验证队列。在验证队列中检验了在开发队列中开发的 CVD 风险预测模型的校准情况。在校准评估后,还对长期趋势进行了建模。最后,在边际结构模型框架下评估了长期趋势的存在,该框架中调整了随访期间他汀类药物治疗的效果。

结果

如果不建模长期趋势,在验证队列中会发现风险的严重过高预测。如果明确建模长期趋势,则可以最小化这种校准错误。在引入长期趋势后,验证队列中的风险降低分别为女性队列和男性队列的 35.68%和 33.24%。在边际结构模型框架下,降幅分别为 33.31%和 32.67%,表明随访期间他汀类药物使用的增加并不是长期趋势的唯一原因。

结论

将长期趋势纳入模型后,心血管疾病风险预测发生了重大变化。英国临床实践中使用的模型并未对长期趋势进行建模,因此可能过高估计了风险,可能导致不必要的患者治疗。需要更广泛地讨论在风险预测框架中对长期趋势进行建模的问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dbf/7706224/c338c6cd6cc8/12874_2020_1173_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dbf/7706224/81c06c06bfe9/12874_2020_1173_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dbf/7706224/d72af0dbf893/12874_2020_1173_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dbf/7706224/8b697aeb77cc/12874_2020_1173_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dbf/7706224/c338c6cd6cc8/12874_2020_1173_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dbf/7706224/81c06c06bfe9/12874_2020_1173_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dbf/7706224/d72af0dbf893/12874_2020_1173_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dbf/7706224/8b697aeb77cc/12874_2020_1173_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dbf/7706224/c338c6cd6cc8/12874_2020_1173_Fig4_HTML.jpg

相似文献

1
An assessment of the potential miscalibration of cardiovascular disease risk predictions caused by a secular trend in cardiovascular disease in England.评估英格兰心血管疾病中存在的长期趋势可能对心血管疾病风险预测造成的潜在误判。
BMC Med Res Methodol. 2020 Nov 30;20(1):289. doi: 10.1186/s12874-020-01173-x.
2
The uncertainty with using risk prediction models for individual decision making: an exemplar cohort study examining the prediction of cardiovascular disease in English primary care.使用风险预测模型进行个体决策的不确定性:以英国初级保健中心血管疾病预测为例的队列研究
BMC Med. 2019 Jul 17;17(1):134. doi: 10.1186/s12916-019-1368-8.
3
The implications of competing risks and direct treatment disutility in cardiovascular disease and osteoporotic fracture: risk prediction and cost effectiveness analysis.竞争风险和直接治疗不良反应在心血管疾病和骨质疏松性骨折中的意义:风险预测和成本效益分析。
Health Soc Care Deliv Res. 2024 Feb;12(4):1-275. doi: 10.3310/KLTR7714.
4
Prediction of Cardiovascular Disease Risk Accounting for Future Initiation of Statin Treatment.考虑未来开始使用他汀类药物治疗的情况下预测心血管疾病风险。
Am J Epidemiol. 2021 Oct 1;190(10):2000-2014. doi: 10.1093/aje/kwab031.
5
Validation of the atherosclerotic cardiovascular disease Pooled Cohort risk equations.验证动脉粥样硬化性心血管疾病的汇总队列风险方程。
JAMA. 2014 Apr 9;311(14):1406-15. doi: 10.1001/jama.2014.2630.
6
The efficiency of cardiovascular risk assessment: do the right patients get statin treatment?心血管风险评估的效率:合适的患者是否得到他汀类药物治疗?
Heart. 2013 Nov;99(21):1597-602. doi: 10.1136/heartjnl-2013-303698. Epub 2013 Jun 4.
7
Long-term health outcomes of people with reduced kidney function in the UK: A modelling study using population health data.英国肾功能降低人群的长期健康结局:基于人群健康数据的建模研究。
PLoS Med. 2020 Dec 16;17(12):e1003478. doi: 10.1371/journal.pmed.1003478. eCollection 2020 Dec.
8
Predictive performance of a competing risk cardiovascular prediction tool CRISK compared to QRISK3 in older people and those with comorbidity: population cohort study.竞争风险心血管预测工具 CRISK 与 QRISK3 在老年人和合并症患者中的预测性能比较:人群队列研究。
BMC Med. 2022 May 4;20(1):152. doi: 10.1186/s12916-022-02349-6.
9
Sub-optimal cholesterol response to initiation of statins and future risk of cardiovascular disease.起始他汀类药物治疗后胆固醇反应不佳与未来心血管疾病风险。
Heart. 2019 Jul;105(13):975-981. doi: 10.1136/heartjnl-2018-314253. Epub 2019 Apr 15.
10
An observational study of how clinicians use cardiovascular risk assessment to inform statin prescribing decisions.一项关于临床医生如何利用心血管风险评估来指导他汀类药物处方决策的观察性研究。
N Z Med J. 2017 Oct 6;130(1463):28-38.

引用本文的文献

1
A time-adjusted control chart for monitoring surgical outcome variations.用于监测手术结果变化的时间调整控制图。
PLoS One. 2024 May 15;19(5):e0303543. doi: 10.1371/journal.pone.0303543. eCollection 2024.
2
Exploring Clinical Trajectories and the Continuum of Care for Patients With Acute Coronary Syndrome in the United Kingdom: A Thorough Cross-Sectional Analysis.探索英国急性冠状动脉综合征患者的临床轨迹与连续护理:一项全面的横断面分析。
Cureus. 2023 Nov 25;15(11):e49391. doi: 10.7759/cureus.49391. eCollection 2023 Nov.
3
Prognostic model for atrial fibrillation after cardiac surgery: a UK cohort study.

本文引用的文献

1
The uncertainty with using risk prediction models for individual decision making: an exemplar cohort study examining the prediction of cardiovascular disease in English primary care.使用风险预测模型进行个体决策的不确定性:以英国初级保健中心血管疾病预测为例的队列研究
BMC Med. 2019 Jul 17;17(1):134. doi: 10.1186/s12916-019-1368-8.
2
Dynamic models to predict health outcomes: current status and methodological challenges.预测健康结果的动态模型:现状与方法学挑战
Diagn Progn Res. 2018 Dec 18;2:23. doi: 10.1186/s41512-018-0045-2. eCollection 2018.
3
Using marginal structural models to adjust for treatment drop-in when developing clinical prediction models.
心脏手术后心房颤动的预后模型:一项英国队列研究。
Clin Res Cardiol. 2023 Feb;112(2):227-235. doi: 10.1007/s00392-022-02068-1. Epub 2022 Aug 5.
使用边缘结构模型在开发临床预测模型时调整治疗脱落。
Stat Med. 2018 Dec 10;37(28):4142-4154. doi: 10.1002/sim.7913. Epub 2018 Aug 2.
4
Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study.用于估计心血管疾病未来风险的QRISK3风险预测算法的开发与验证:前瞻性队列研究
BMJ. 2017 May 23;357:j2099. doi: 10.1136/bmj.j2099.
5
Robust causal inference using directed acyclic graphs: the R package 'dagitty'.使用有向无环图进行稳健的因果推断:R包“dagitty”
Int J Epidemiol. 2016 Dec 1;45(6):1887-1894. doi: 10.1093/ije/dyw341.
6
Trends in the epidemiology of cardiovascular disease in the UK.英国心血管疾病流行病学趋势
Heart. 2016 Dec 15;102(24):1945-1952. doi: 10.1136/heartjnl-2016-309573. Epub 2016 Aug 22.
7
Data Resource Profile: Clinical Practice Research Datalink (CPRD).数据资源简介:临床实践研究数据链(CPRD)
Int J Epidemiol. 2015 Jun;44(3):827-36. doi: 10.1093/ije/dyv098. Epub 2015 Jun 6.
8
Determinants of the decline in mortality from acute myocardial infarction in England between 2002 and 2010: linked national database study.2002 年至 2010 年期间英格兰急性心肌梗死死亡率下降的决定因素:关联国家数据库研究。
BMJ. 2012 Jan 25;344:d8059. doi: 10.1136/bmj.d8059.
9
UK stroke incidence, mortality and cardiovascular risk management 1999-2008: time-trend analysis from the General Practice Research Database.1999-2008 年英国卒中发病率、死亡率和心血管风险管理:来自普通实践研究数据库的时间趋势分析。
BMJ Open. 2011 Jan 1;1(2):e000269. doi: 10.1136/bmjopen-2011-000269.
10
An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study.QRISK2 心血管疾病风险评分的独立和外部验证:一项前瞻性开放队列研究。
BMJ. 2010 May 13;340:c2442. doi: 10.1136/bmj.c2442.